Skip to main content

Research Repository

Advanced Search

Serum 25-Hydroxyvitamin D3 levels are associated with Breslow thickness at presentation, and survival from melanoma.

Newton-Bishop, J A; Beswick, A; Randerson-Moor, J; Chang, Y M; Affleck, P; Elliott, F; Chan, M; Leake, S; Karpavicius, B; Haynes, S; Kukalizch, K; Whitaker, L; Jackson, S; Gerry, E; Nolan, C; Bertram, C; Marsden, J; Elder, D E; Barrett, J H; Bishop, D T

Authors

J A Newton-Bishop

A Beswick

J Randerson-Moor

Y M Chang

P Affleck

F Elliott

M Chan

S Leake

B Karpavicius

S Haynes

K Kukalizch

L Whitaker

S Jackson

E Gerry

C Nolan

C Bertram

J Marsden

D E Elder

J H Barrett

D T Bishop



Citation

Newton-Bishop, J. A., Beswick, A., Randerson-Moor, J., Chang, Y. M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., Kukalizch, K., Whitaker, L., Jackson, S., Gerry, E., Nolan, C., Bertram, C., Marsden, J., Elder, D. E., Barrett, J. H., & Bishop, D. T. Serum 25-Hydroxyvitamin D3 levels are associated with Breslow thickness at presentation, and survival from melanoma. Journal of Clinical Oncology, 27(32), 5439-5444. https://doi.org/10.1200/JCO.2009.22.1135

Journal Article Type Article
Deposit Date Nov 12, 2014
Journal Journal of Clinical Oncology
Print ISSN 0732-183X
Electronic ISSN 1527-7755
Publisher American Society of Clinical Oncology
Volume 27
Issue 32
Pages 5439-5444
DOI https://doi.org/10.1200/JCO.2009.22.1135
Public URL https://rvc-repository.worktribe.com/output/1426806
Additional Information Corporate Creators : Pennsylvania, Philadelphia, St James University Hosp, Leeds, University Hospital Birmingham